‪Jagat R Kanwar, Kanwar R. Jagat, Rakesh Jagat, Rakesh J, JR Kanwar‬

Navedeno

	Vse	Od leta 2020
Navedbe	13053	4638
indeks h	63	33
indeks i10	205	124

1100

550

275

825

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202549 95 132 157 163 154 147 149 235 413 604 638 703 944 952 906 890 892 968 1046 890 867 730 137

Javni dostop

Prikaži vse

51 člankov

21 člankov

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

Dr Rupinder K KanwarAll India Institute of Medical Sciences (AIIMS), Bhopal, M.P. IndiaPreverjeni e-poštni naslov na aiimsbhopal.edu.in
Dr Sasidharan SreenivasanAssociate Professor, Universiti Sains MalaysiaPreverjeni e-poštni naslov na usm.my
kishlay royAlfred Deakin Postdoctoral Research FellowPreverjeni e-poštni naslov na deakin.edu.au
Krishnakumar subramanianProfessor of Ocular Pathology,L&T Ocular Pathology DepartmentPreverjeni e-poštni naslov na snmail.org
CHEN YENGDepartment of Oral & Craniofacial Sciences. Faculty of Dentistry, University of MalayaPreverjeni e-poštni naslov na um.edu.my
Chun Hei Antonio CheungNational Cheng Kung UniversityPreverjeni e-poštni naslov na mail.ncku.edu.tw
Dr Jothy LachumyNanyang Technological University, SingaporePreverjeni e-poštni naslov na ntu.edu.sg
Shufeng Zhou, MD & PhDProfessor, Huaqiao UniversityPreverjeni e-poštni naslov na hqu.edu.cn
Euphemia LeungUniversity of AucklandPreverjeni e-poštni naslov na auckland.ac.nz
colin barrowDeakin UniversityPreverjeni e-poštni naslov na deakin.edu.au
Sara BaratchiAssociate Professor, Baker Heart and Diabetes InstitutePreverjeni e-poštni naslov na baker.edu.au
Vikas Khetan DO, DNB, FACS, FRCS...Professor, Flaum Eye Institute, Rochester, NYPreverjeni e-poštni naslov na urmc.rochester.edu
Chern Ein OonINFORMM, Universiti Sains MalaysiaPreverjeni e-poštni naslov na usm.my
Dr.Sishir Kumar KamalapuramDeakin University, Australia.Preverjeni e-poštni naslov na sanjeevanibio.com
Vasu PunjAssociate ProfessorPreverjeni e-poštni naslov na usc.edu
Rasika SamarasingheLecturer in Medical SciencePreverjeni e-poštni naslov na deakin.edu.au
Prof. Dr. Prasad NEERATIProfessor of Pharmacology, Kakatiya UniversityPreverjeni e-poštni naslov na kakatiya.ac.in
Klaus LehnertAssociate Professor, University of Auckland, School of Biological SciencesPreverjeni e-poštni naslov na auckland.ac.nz
Rakesh N VeeduAssociate Professor at Murdoch University & Perron InstitutePreverjeni e-poštni naslov na murdoch.edu.au
Abbas KouzaniProfessor, Deakin UniversityPreverjeni e-poštni naslov na deakin.edu.au

Spremljaj

Jagat R Kanwar, Kanwar R. Jagat, Rakesh Jagat, Rakesh J, JR Kanwar

All India Institute of Medical Sciences (AIIMS), Bhopal, INDIA, MP.

Preverjeni e-poštni naslov na aiimsbhopal.edu.in

Biochemistry Precision-Nanomedicine Targeted-Nano-Theranostics Cancer Inflammation


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives D Chen, M Frezza, S Schmitt, J Kanwar, Q P Dou Current cancer drug targets 11 (3), 239-253, 2011	1006	2011
Progress on Azadirachta indica based biopesticides in replacing synthetic toxic pesticides S Chaudhary, RK Kanwar, A Sehgal, DM Cahill, CJ Barrow, R Sehgal, ... Frontiers in Plant Science 8, 610, 2017	422	2017
Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy X Sun, JR Kanwar, E Leung, K Lehnert, D Wang, GW Krissansen Gene therapy 8 (8), 638-645, 2001	311	2001
Recent advances on the roles of NO in cancer and chronic inflammatory disorders JR Kanwar, RK Kanwar, H Burrow, S Baratchi Current medicinal chemistry 16 (19), 2373-2394, 2009	293	2009
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy JR Kanwar, WP Shen, RK Kanwar, RW Berg, GW Krissansen Journal of the National Cancer Institute 93 (20), 1541-1552, 2001	254	2001
Microfluidic devices for cell cultivation and proliferation M Tehranirokh, AZ Kouzani, PS Francis, JR Kanwar Biomicrofluidics 7 (5), 2013	205	2013
Treat cancers by targeting survivin: just a dream or future reality? MS Coumar, FY Tsai, JR Kanwar, S Sarvagalla, CHA Cheung Cancer treatment reviews 39 (7), 802-811, 2013	193	2013
Herb-drug interactions and mechanistic and clinical considerations XW Chen, K B Sneed, SY Pan, C Cao, J R Kanwar, H Chew, SF Zhou Current drug metabolism 13 (5), 640-651, 2012	191	2012
Mouse B7-H3 induces antitumor immunity X Sun, M Vale, E Leung, JR Kanwar, R Gupta, GW Krissansen Gene therapy 10 (20), 1728-1734, 2003	186	2003
Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1) SM He, R Li, J R Kanwar, SF Zhou Current medicinal chemistry 18 (3), 439-481, 2011	176	2011
Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6 SL Mo, YH Liu, W Duan, MQ Wei, JR Kanwar, SF Zhou Current drug metabolism 10 (7), 730-753, 2009	175	2009
Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal JR Kanwar, X Sun, V Punj, B Sriramoju, RR Mohan, SF Zhou, A Chauhan, ... Nanomedicine: Nanotechnology, Biology and Medicine 8 (4), 399-414, 2012	168	2012
Chimeric aptamers in cancer cell-targeted drug delivery JR Kanwar, K Roy, RK Kanwar Critical reviews in biochemistry and molecular biology 46 (6), 459-477, 2011	166	2011
Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions JR Kanwar, K Roy, Y Patel, SF Zhou, MR Singh, D Singh, M Nasir, ... Molecules 20 (6), 9703-9731, 2015	165	2015
Targeting survivin in cancer: the cell-signalling perspective JR Kanwar, SK Kamalapuram, RK Kanwar Drug discovery today 16 (11-12), 485-494, 2011	156	2011
Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats G Tan, S Pan, J Li, X Dong, K Kang, M Zhao, X Jiang, JR Kanwar, H Qiao, ... PloS one 6 (10), e25943, 2011	149	2011
Evaluation of the cytotoxicity, cell-cycle arrest, and apoptotic induction by Euphorbia hirta in MCF-7 breast cancer cells YP Kwan, T Saito, D Ibrahim, FMS Al-Hassan, C Ein Oon, Y Chen, ... Pharmaceutical biology 54 (7), 1223-1236, 2016	148	2016
Receptor mediated tumor targeting: an emerging approach for cancer therapy C Mohanty, M Das, J R Kanwar, S K Sahoo Current drug delivery 8 (1), 45-58, 2011	147	2011
Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy M Puri, I Kaur, RK Kanwar, RC Gupta, A Chauhan, JR Kanwar Current Molecular Medicine 9 (9), 1080-1094, 2009	140	2009
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier JR Kanwar, B Sriramoju, RK Kanwar International journal of nanomedicine, 3259-3278, 2012	134	2012

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji